← feed

Is NCT02669511 results overdue?

Yes — results are overdue. Primary completion was 2018-01-12; the FDAAA-801 reporting deadline (2019-01-12) passed 2717 days ago and no results are posted on ClinicalTrials.gov.

PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma

NCT IDNCT02669511 ↗
SponsorPIQUR Therapeutics AG (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2018-01-12 (ACTUAL)
Reporting deadline2019-01-12 (completion + 365d)
Days overdue2717
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 3234696137c65cca… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02669511. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →